NCT01707667 - Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 27, 2013

Primary Completion Date

November 27, 2013

Study Completion Date

November 27, 2013

Conditions

Chronic Constipation

Interventions

DRUG

prucalopride

One 2 mg tablet orally administered on Day 1

DRUG

PEG 3350

13.8g polyethylene glycol (PEG) 3350 with sodium bicarbonate, sodium chloride, and potassium chloride as a solution in water. Administered twice orally on Day 1(once in the morning and once prior to lunch).

Trial Locations (3)

3000

UNIVERSITY OF LEUVEN, UNVERSITY HOSPITAL, Gasthuisberg, Leuven

73104

Oklahoma Foundation for Digestive Research, Oklahoma City

E1 1BB

Barts Health NHS Trust, Whitechapel